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This article investigated the efﬁcacy of the combination of anti-
epileptic drug therapy in protecting against soman-induced
seizure severity, epileptogenesis and performance deﬁcits. Adult
male rats with implanted telemetry transmitters for continuous
recording of electroencephalographic (EEG) activity were exposed
to soman and treated with atropine sulfate and the oxime HI-6 one
minute after soman exposure and with midazolam, ketamine and/
or valproic acid 40 min after seizure onset. Rats exposed to soman
and treated with medical countermeasures were evaluated for
survival, seizure severity, the development of spontaneous recur-
rent seizure and performance deﬁcits; combination anti-epileptic
drug therapy was compared with midazolam monotherapy.
Telemetry transmitters were used to record EEG activity, and a
customized MATLAB algorithm was used to analyze the telemetry
data. Survival data, EEG power integral data, spontaneous recur-
rent seizure data and behavioral data are illustrated in ﬁgures and
included as raw data. In addition, edf ﬁles of one month telemetry
recordings from soman-exposed rats treated with delayed. Lumley).
en access article under the CC BY-NC-ND license (http://creativecommons.
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ical exposure-induced performance deﬁcits [2,3].1. Data
The ﬁrst set of data corresponds to a dose-response experiment of delayed treatment with mid-
azolam in soman-exposed rats. Fig. 1A is a survival plot of soman-exposed rats treated with a dose
range of midazolam at 40 min after seizure onset. Fig. 1B is a bar graph illustrating the EEG power
integral at 1 h and 6 h after soman exposure in rats treated with midazolam. Fig. 1C and D illustrate the
percentage of rats that developed SRS and the number of SRS, respectively. Corresponding raw data are
Fig. 1. Delayed midazolam increases survival but does not prevent status epilepticus or epileptogenesis. A) Midazolam administered
40 min after the onset of seizures induced by soman (GD) dose-dependently increased survival to GD: rats that received saline (GD/
SAL; n ¼ 10) or low midazolam (1 mg/kg; GD/MDZ1; n ¼ 14) had poor survival (30% and 50% respectively), while those that received
3 mg/kg midazolam (GD/MDZ3; n ¼ 13) or 9 mg/kg midazolam (GD/MDZ9; n ¼ 13) had 85e90% survival. B) Soman exposure
increased EEG power integral during status epilepticus. Treatment with midazolam (3 or 9 mg/kg) at 40 min after seizure onset
reduced GD-induced seizure severity compared to saline treatment as shown by power integral during the 1 h period after treat-
ment. Data shown are mean ± SEM. C) Following a latent period of 1e2 weeks, all of the surviving GD-exposed rats treated with
saline or with 1 mg/kg midazolam developed SRS, while 57 and 70% of those treated with 3 mg/kg and 9 mg/kg midazolam,
respectively developed SRS. D) Number of SRS is shown as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001.
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Fig. 1D, SRS onset and #).
Four representative telemetry recordings of over one month of continuous data from soman
exposed rats treated with one of three doses (1, 3, 9 mg/kg; ip) of midazolam are provided in Mendeley
Data Direct (URL to data: https://doi.org/10.17632/zwcx948yjc.2) as supplementary materials in a data
repository. Each folder contains raw EEG data compressed into 7zip format split into 3e4 volumes.
After uncompressing (we suggest using https://www.7-zip.org) the set of ﬁles for each animal, the
recordings can be accessed using EDF (European Data Format)-compatible software and contain signals
collected at 250 Hz from two EEG channels, one signal strength channel (used for assessing grossmotor
activity) and one body temperature channel, and include baseline and post-exposure to soman data.
The animal identiﬁcation and date/time of each recording were modiﬁed per IACUC suggestion with
date set back to 2000. A05_GD_MDZ3.edf is from a GD-exposed rat treated with 3 mg/kg midazolam
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5/2000 at 21:55 (actual 10:04 a.m., which is ~2 hr after onset of the dark cycle). Since the exposure was
performed in a hood in another room, there is an interruption of signal during this period (between 21:
52e21:57), followed by seizure onset at 22:03 (with seizure latency of 8 min). Treatment time (40 min
after seizure onset), characterized by a short signal interruption is 22:43. For A06_GD_MDZ1.edf from a
GD exposed rat treated with 1 mg/kg midazolam that had over 30 SRS, the modiﬁed date and time
stamp has exposure on 1/5/2000 at 22:47 with a data gap between 22:44 and 22:49 and seizure onset
at 22:50 with seizure latency of 3 min. Treatment time (40 min after seizure onset), characterized by a
short signal interruption is 23:30. For A08_GD_MDZ9.edf from a GD exposed rat treated with 9 mg/kg
midazolam that had less than 5 SRS, themodiﬁed date and time stamp has exposure on 1/5/2000 at 22:
11 with a data gap between 22:08 and 22:13 and seizure onset at 22:19 with seizure latency of 8 min.
Treatment time (40 min after seizure onset), characterized by a short signal interruption was 22:58. A
fourth animal A09_GD_MDZ3.edf from a soman exposed rat treated with 3 mg/kg midazolam is
included to illustrate an animal with an extremely large number of SRS (over 100 SRS). The modiﬁed
date and time stamp has exposure on1/5/2000 at 22:43 with a data gap between 22:40 and 22:45 and
seizure onset at 22:49 with seizure latency of 7 min. Treatment time (40 min after seizure onset),
characterized by a short signal interruption is 23:30.
The second set of data corresponds to a dose-response study of ketamine monotherapy or as an
adjunct to midazolam against soman-induced toxicity in rats. Survival plots are shown in Fig. 2A
(ketamine monotherapy) and Fig. 2B (ketamine and midazolam combination). Fig. 2C is a bar graph
illustrating the effect that midazolam and ketamine dual therapy had on EEG power integral (a
measure of seizure severity) compared to vehicle or midazolam monotherapy at 1 h after treatment.
Some of these data are captured in Fig. 2B in Niquet et al. [1], with additional groups shown here. The
number of rats that develop SRS are in Fig. 3C in Niquet et al. [1], and in Fig. 2D in Niquet et al. [4]. Raw
data for Fig. 2 is in a supplementary excel ﬁle titled “Data Combination Therapy Against Soman”
(Fig. 2A, KET survival; Fig. 2B, MDZKET Survival; Fig. 2C, KET&MDZKET Power).We present data from a
comparison of the effects of monotherapy and dual therapy on performance deﬁcits that follow soman
exposure. Latency to locate the platform in theMorris watermaze is shown in Fig. 3E in Niquet et al. [1]
and Fig. 2F, Niquet et al. [4] with raw data in the excel ﬁle “Morris Water Maze.” Additional measures of
performance in the Morris water maze are shown in Fig. 3A (Training sessions percent time in target
quadrant), 3B (Training sessions distance travelled), 3C (Training sessions thigmotaxis), and 3D (Probe
trial Gallagher score) with raw data included in the supplementary excel ﬁle (Morris water maze). We
also provide data from an evaluation of the efﬁcacy of adding valproic acid to a combination therapy of
ketamine and midazolam against soman-induced seizure severity [4]. Raw data for Fig. 1B in Niquet
et al. [4] is included in the excel ﬁle labelled “MDZ_KET_VPA_Power.”2. Experimental design, materials, and methods
2.1. Animals
Male Sprague-Dawley rats (350e400 g; Charles River) individually housed and maintained on a
reverse, 12 h light-dark cycle were implanted with F40-EET telemetry transmitters [Data Sciences
International (DSI), Inc., St. Paul, MN, USA] for the continuous EEGmonitoring. Rats wereweighed daily,
and treatment groups were counterbalanced according to pre-exposure weight. The experimental
protocol was approved by the Animal Care and Use Committee at the United States Army Medical
Research Institute of Chemical Defense, and all procedures were conducted in accordance with the
principles stated in the Guide for the Care and Use of Laboratory Animals (National Research Council,
2011), the Public Health Service Policy on Humane Care and Use of Laboratory Animals and the Animal
Welfare Act of 1966 (P.L. 89e544), as amended.
Fig. 2. A dose range of ketamine (KET; 10, 30, 90 mg/kg; n ¼ 7e11/group) with or without midazolam (MDZ) was administered
40 min after soman (GD)-induced seizure onset. A) GD-exposed rats treated with KET (60 mg/kg; GD/KET60) had a high survival
rate, while those treated with 10 mg/kg (GD/KET10) or 90 mg/kg KET (GD/KET90) had a poor survival rate. B) GD-exposed rats
administered KET (30 mg/kg) in combination with midazolam (MDZ; 3 mg/kg; GD/MDZ3/KET30) had a high survival rate, while
those treated with 60 or 90 mg/kg of KET in combination with MDZ (GD/MDZ3/KET60 or GD/MDZ3/KET90, respectively) had poor
survival. C) Combination of KET (30 mg/kg) and MDZ (3 mg/kg; GD/MDZ/KET30) signiﬁcantly reduced the EEG ratio power integral
1 h after treatment compared to MDZ monotherapy (GD/MDZ3) or to vehicle (GD/VEH) or to KET (GD/KET30 or GD/KET60). Data
shown are mean ± SEM. *p < 0.05.
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Rats were subcutaneously (s.c.) administered 1.2 LD50 soman (pinacolyl methylphosphono-
ﬂuoridate; 132 mg/kg; 0.5 ml/kg) obtained from the U.S. Army Combat Capabilities Development
Command Chemical Biological Center (Aberdeen Proving Ground, MD, USA) and 1 min later admin-
istered an intramuscular (i.m.) injectionwith an admix of atropine sulfate (2 mg/kg; Sigma Aldrich; St.
Louis, MO, USA) and the oxime HI-6 dimethanesulfonate salt (118.5 mg/kg; Starkes Associates, Buffalo,
NY, USA). Forty minutes after seizure onset, drugs were administered intraperitoneally (i.p.). Treat-
ments included midazolam (1, 3, or 9 mg/kg; Hospira, Lake Forest, IL, USA), ketamine (10, 30, 60, or
90 mg/kg; Mylan, Canonsburg, PA, USA), and/or valproic acid (90 mg/kg; Sigma-Aldrich, St. Louis, MO,
USA).
Fig. 3. Ketamine (KET; 30 mg/kg) with or without midazolam (MDZ; 3 mg/kg) was administered 40 min after soman (GD)-induced
seizure onset and compared with no agent control mice (n ¼ 10e11/group). Morris water maze testing was conducted one month
after GD exposure. GD-exposed rats treated with combination therapy of KET and MDZ (GD/MDZ/KET) performed similarly to no-
agent control (No GD) rats. Rats treated with MDZ monotherapy (GD/MDZ) or KET monotherapy (GD/KET) spent less time in the
target quad (A), had greater distance travelled (B), spent more time in thigmotaxis (C), had greater cumulative distance in the probe
trial compared to no-agent control rats (D), and had greater latency to locate the platform [1,4]. Data shown are mean ± SEM.
*p < 0.05.
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Rats anesthetized with isoﬂurane were surgically implanted with F40-EET telemetry transmitters
(DSI, Inc.) to record bi-hemispheric cortical EEG activity as previously described [5]. Following 7e10
days of recovery, rats were exposed to soman and monitored for seizure onset. For EEG activity
recording, an RPC-1 physiotel receiver from DSI was placed under each rat's home cage for continuous
data collection (24 h/day) using Dataquest ART Acquisition software (DSI, Inc.). The Dataquest EEG ﬁles
were converted to European Data Format (edf) [6] using Neuroscore 1.1.1 (DSI), and the EEG channel
with the best signal-to-noise ratio was chosen for each animal. Signals from each EEG channel were
visually screened to identify the presence of artifacts, and the channel with the least number of arti-
facts was chosen for further analysis. In case several data sets were accumulated per animal, the
datasets were linked to each other in MATLAB, allowing proper representation of the data. The signal
was ﬁltered using a Butterworth ﬁlter (pass band of 0.1e125 Hz; notch ﬁlter of 60 Hz [7]). Epileptiform
activity was identiﬁed using Dataquest ART 4.1 (analysis software), Neuroscore 1.1.1 (DSI), and a
customized MATLAB (MATLAB; Mathworks, 2008a) algorithm according to de Araujo Furtado et al. [7]
and conﬁrmed by visual screening. Converted edf ﬁles were analyzed to identify the time spent in
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the average of power spectra of each hour period through a customized MATLAB algorithm and
applying a formula [decibels ¼ 10*(Log(V^2sample/V^2normal))]*60 min, resulting in decibels/h. The
range of frequency analyzed was 0.1e100 Hz, and the data represent the full spectrum and the ratio of
power of EEG signal in the ﬁrst 24 h and in speciﬁc time periods of 1 and 6 hours after onset of status
epilepticus.2.4. Behavioral assessments
One month after soman exposure and treatment, rats were evaluated for spatial memory acquisi-
tion and retention in theMorris water maze (MWM) test. A hidden platform (10 10 cm)was placed in
a ﬁxed position 1.25 cm below the surface of a 170 cm diameter pool ﬁlled with paint-blackened water
(26 ± 1 C; for detailed methods, see Schultz et al. [5]). Brieﬂy, rats received four 60 s trials per session,
2 training sessions per day and a 30 min rest period between sessions for a total of 8 trials/day. After
three training days (6 training sessions total), the platformwas removed, and two 60 s probe trials were
conducted. A video tracking program (HVS Watermaze 2100, HVS Image, Cambridge, UK) was used to
measure latency to escape, path length, speed, heading error, thigmotaxis, target quad time, Gallagher
score [8], and number of platform passes (deﬁnitions listed below). Following the second probe test, a
visual acuity test was conducted in which the latency to locate a visible platform was evaluated over
four successive 60 s trials. Data are included in supplementary material (excel sheet 9) with corre-
sponding labels listed below.
2.4.1. Latency to escape
Time in seconds from the start of the trial for the rat to reach the platform and end the trial. A
maximum latency of 60 s is assigned if the rat fails to ﬁnd the platform in 60 s. In the supplementary
excel ﬁle, listed as S1Lat, S2Lat, etc.
2.4.2. Path length
The length of the path that the rat took from the starting location to its location at the end of the trial
(meters). Listed in supplementary excel data ﬁle as S1Path, S2Path, etc.
2.4.3. Speed
Average speed over entire trial (meters per second), path length/latency. Listed in supplementary
excel data ﬁle as S1Speed, S2Speed, etc.
2.4.4. Heading error
The absolute value of the angle between the platform, the rat's starting position, and the rat's
position after traveling 20 cm. A smaller heading error indicates a more accurate initial direction of the
rat navigating towards the platform. Listed in supplementary excel data ﬁle as S1Head, S2Head, etc. For
probe trial, listed as P1Head, P2Head.
2.4.5. Thigmotaxis
The percent of trial time the rat spent in the perimeter of the water maze. Listed in supplementary
excel data ﬁle as S1Thig, S2Thig, etc.
2.4.6. Target quadrant time
The percent of trial time the rat spent in the target quadrant. Listed in supplementary excel data ﬁle
as S1TargetQuad, S2TargetQuad, etc.
2.4.7. Gallagher score (cumulative)
The Gallagher score is the distance between the rat and the platform at every second in the trial [8].
The cumulative version is the total Gallagher score for the entire trial. Listed in supplementary excel
data ﬁle as S1GalCum, S2GalCum, etc. For probe trial, listed as P1Gal, P2Gal.
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Number of times during the probe trial that the rat passed through the platform location. Listed in
supplementary excel data ﬁle as P1Pass, P2Pass.
2.5. Statistical analysis
Statistical analyses were performed using SPSS (IBM Inc, Armonk, NY), and graphs were compiled
using SigmaPlot (Systat Software Inc., San Jose, CA). Survival across time and spontaneous recurrent
seizure onset were analyzed with a Kaplan-Meier analysis, followed by a log-rank test to determine
treatment effect on the distributions. EEG power integral were analyzed using an ANOVA. Signiﬁcant
interactions were followed up at each time point (baseline, 1 hr, 6 hr) followed by multiple compar-
isons of treatment groups. Measures in the Morris water maze were analyzed using a repeated mea-
sures ANOVA. For signiﬁcant interactions between group and repeat (time or trial), a one-way ANOVA
was used to compare groups at each repeat and to compare each group over time. Differences were
considered statistically signiﬁcant when p < 0.05.
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